Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome

被引：6
|
作者：
Frater, J
Dunn, D
Weber, JN
McClure, MO
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Div Med, Wright Fleming Inst, Jefferiss Res Labs, London W2 1PG, England
[2] MRC, HIV Clin Trials Unit, London, England
来源：
JOURNAL OF INFECTIOUS DISEASES | 2002年 / 185卷 / 09期
关键词：
D O I：
10.1086/340127
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1376 / 1376
页数：1
相关论文
共 50 条
  • [1] Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome - Reply
    Perno, CF
    Cozzi-Lepri, A
    Balotta, C
    Monforte, AD
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09): : 1376 - 1377
  • [2] Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors
    Svicher, V
    Ceccherini-Silberstein, F
    Erba, F
    Santoro, M
    Gori, C
    Bellocchi, MC
    Giannella, S
    Trotta, MP
    Monforte, AD
    Antinori, A
    Pern, CF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) : 2015 - 2025
  • [3] Human immunodeficiency virus type 1 protease inhibitors
    McDonald, CK
    Kuritzkes, DR
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (09) : 951 - 959
  • [4] Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease
    Bukovsky, AA
    Dorfman, T
    Weimann, A
    Gottlinger, HG
    JOURNAL OF VIROLOGY, 1997, 71 (02) : 1013 - 1018
  • [5] Positive Selection Pressure Introduces Secondary Mutations at Gag Cleavage Sites in Human Immunodeficiency Virus Type 1 Harboring Major Protease Resistance Mutations
    Banke, Soren
    Lillemark, Marie R.
    Gerstoft, Jan
    Obel, Niels
    Jorgensen, Louise B.
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 8916 - 8924
  • [6] Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors
    Acosta, EP
    Kakuda, TN
    Brundage, RC
    Anderson, PL
    Fletcher, CV
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S151 - S159
  • [7] Resistance to human immunodeficiency virus type 1 protease inhibitors
    Boden, D
    Markowitz, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2775 - 2783
  • [8] Mutations in the Thumb Allow Human Immunodeficiency Virus Type 1 Reverse Transcriptase To Be Cleaved by Protease in Virions
    Dunn, Linda L.
    McWilliams, Mary Jane
    Das, Kalyan
    Arnold, Eddy
    Hughes, Stephen H.
    JOURNAL OF VIROLOGY, 2009, 83 (23) : 12336 - 12344
  • [9] Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
    Shahriar, Rajin
    Rhee, Soo-Yon
    Liu, Tommy F.
    Fessel, W. Jeffrey
    Scarsella, Anthony
    Towner, William
    Holmes, Susan P.
    Zolopa, Andrew R.
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4869 - 4878
  • [10] Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations
    Muzammil, S.
    Armstrong, A. A.
    Kang, L. W.
    Jakalian, A.
    Bonneau, P. R.
    Schmelmer, V.
    Amzel, L. M.
    Freire, E.
    JOURNAL OF VIROLOGY, 2007, 81 (10) : 5144 - 5154
12345